Advisors Asset Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$923K Sell
14,412
-27,991
-66% -$1.84M 0.01% 815
2026
Q1
$3.02M Sell
42,403
-16,929
-29% -$1.33M 0.05% 473
2025
Q4
$4.87M Sell
59,332
-18,800
-24% -$1.46M 0.08% 331
2025
Q3
$5.87M Sell
78,132
-16,486
-17% -$1.23M 0.1% 281
2025
Q2
$7.01M Sell
94,618
-11,435
-11% -$796K 0.13% 204
2025
Q1
$8.56M Buy
106,053
+1,710
+2% +$147K 0.16% 145
2024
Q4
$8.16M Buy
104,343
+6,913
+7% +$588K 0.15% 156
2024
Q3
$9.14M Buy
97,430
+21,413
+28% +$1.8M 0.17% 138
2024
Q2
$5.92M Buy
76,017
+25,440
+50% +$2.08M 0.12% 218
2024
Q1
$4.6M Buy
50,577
+18,075
+56% +$1.5M 0.09% 286
2023
Q4
$2.51M Buy
32,502
+21,985
+209% +$1.54M 0.05% 452
2023
Q3
$716K Buy
10,517
+10,219
+3,429% +$744K 0.02% 806
2023
Q2
$24.2K Buy
+298
New +$23.8K ﹤0.01% 1352

Other funds holding GEHC

Advisors Asset Management's GEHC Position: Q2 2026 in Review

Advisors Asset Management reduced its GE HealthCare (GEHC) stake by 66% in Q2 2026, selling an estimated $1.84M and leaving 14,412 shares worth $923K. The position accounts for 0.01% of the portfolio, ranked #815.

Advisors Asset Management first reported a position in GEHC in Q2 2023 and has held it in 13 quarters since. The position peaked at $9.14M in Q3 2024. 1,226 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Advisors Asset Management held 14,412 shares of GE HealthCare worth $923K as of Q2 2026.
  • Advisors Asset Management sold 27,991 GE HealthCare shares in Q2 2026, an estimated $1.84M.
  • GE HealthCare made up 0.01% of Advisors Asset Management's portfolio in Q2 2026, its #815 holding.
  • Advisors Asset Management first reported a position in GE HealthCare in Q2 2023 and has held it in 13 quarters since.
  • Advisors Asset Management's GE HealthCare position peaked at $9.14M in Q3 2024.
  • 1,226 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Advisors Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.